Stockreport

Revolution Medicines to Report Financial Results for Third Quarter 2025 After Market Close on November 5, 2025

Revolution Medicines, Inc.  (RVMD) 
PDF REDWOOD CITY, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies [Read more]